News

GOG Foundation Announces $3.5 Million Investment In 10 Scholar Investigators and 36 New Investigators

News // Press Releases
August 1, 2019

(PHILADELPHIA, August 1, 2019) – On July 18th the GOG Foundation Education and Mentoring Committee awarded $3.5 million in research grants to 10 scholars and 36 new investigators in gynecologic oncology during the NRG Oncology Semi-Annual Conference in Philadelphia.

“This initiative demonstrates GOG Foundation’s commitment to develop the next generation of GOG Foundation and NRG Oncology leaders in gynecologic oncology,” said Larry J. Copeland, MD, President of the GOG Foundation.

“The programs also aim to enhance the knowledge of the broader GOG-Foundation/NRG Oncology community on current and evolving prevention and treatment strategies for gynecologic and other relevant cancers and on current and evolving clinical and translational research strategies,” said Committee Chair Ronald D.Alvarez, MD, MBA.

Scholar Investigators

The 10 Scholars were selected from among 50 applicants. Scholars will be expected to develop and implement phase II/III trials in gynecologic oncology and advance to leadership positions within the GOG Foundation and NRG Oncology by the end of their award term. Each Scholar Investigator receives a five-year grant (continuation dependent upon progress as assessed by review of annual progress report), a $20,000 annual stipend for their mentor, a $1,500 stipend to support travel to semiannual NRG Oncology meetings, free registration to GOG-F Symposiums and the Society of Gynecologic Oncology (SGO) Clinical Trials Workshop, and up to $50,000 in support of meritorious proposals for clinical trial development.

  • Rebecca Arend, MD – Gynecologic Oncology, University of Alabama at Birmingham
  • Emma Barber, MD – Gynecologic Oncology, Northwestern University
  • Lisa Barroilhet, MD – Gynecologic Oncology, University of Wisconsin-Madison
  • Katherine Fuh, MD, PhD – Gynecologic Oncology, Washington University School of Medicine in St. Louis
  • Stephanie Gailard, MD, PhD – Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center
  • Lilian Gien, MD – Gynecologic Oncology, Sunnybrook Research Institute
  • Debra Richardson, MD – Gynecologic Oncology, The University of Oklahoma Health Sciences Center
  • Ritu Salani, MD, MBA – Gynecologic Oncology, The Ohio State University
  • Shannon Westin, MD, MPH – Gynecologic Oncology, The University of Texas MD Anderson Cancer Center
  • Dmitriy Zamarin, MD, PhD – Medical Oncology, Memorial Sloan Kettering Cancer Center

New Investigators

The 36 New Investigators were chosen from a pool of 75 applicants. New investigators will be expected to become more engaged with the GOG Foundation and NRG Oncology and to learn more about the gynecologic cancer clinical trial development process. Each New Investigator receives a three-year grant, $1,500 stipend to support travel to semiannual NRG Oncology meetings, and free registration to GOG-F Symposiums and the SGO Clinical Trials Workshop.

  • Mariam Al Hilli, MD – Gynecologic Oncology, Cleveland Clinic
  • Jill Alldredge, MD – Gynecologic Oncology, University of Colorado
  • Joyce Barlin, MD – Gynecologic Oncology, Women’s Cancer Care Associates
  • Saveri Bhattacharya, DO –Medical Oncology, Thomas Jefferson University
  • Stephen Bush, MD – Gynecologic Oncology, West Virginia University
  • Yovanni Casablanca, MD – Gynecologic Oncology, Walter Reed National Military Medical Center
  • Lauren Cobb, MD – Gynecologic Oncology, The University of Texas MD Anderson Cancer Center
  • Joshua Cohen, MD – Gynecologic Oncology, University of California, Los Angeles
  • Bradley Corr, MD – Gynecologic Oncology, University of Colorado
  • Erin Crane, MD, MPH – Gynecologic Oncology, Levine Cancer Institute
  • Eric Donnelly, MD – Radiation Oncology, Northwestern University
  • Britt Erickson, MD – Gynecologic Oncology, University of Minnesota
  • Katharine Esselen, MD, MBA – Gynecologic Oncology – Beth Israel Deaconess
  • Erin George, MD – Gynecologic Oncology, University of Pennsylvania
  • Eugenia Girda, MD – Gynecologic Oncology, Rutgers Cancer Institute of New Jersey
  • Allison Gockley, MD – Gynecologic Oncology, Brigham and Women’s Hospital
  • Gregory Gressel, MD, MS – Gynecologic Oncology, Albert Einstein College of Medicine
  • Camille Gunderson, MD, MS – Gynecologic Oncology, University of Oklahoma Stephenson Cancer Center
  • Kathy Han, MD – Radiation Oncology, Princess Margaret Cancer Centre
  • Marilyn Huang, MD, MS – Gynecologic Oncology, University of Miami Sylvester Comprehensive Cancer Center
  • Katherine Kurnit, MD, MPH – Gynecologic Oncology, University of Chicago
  • Lindsay Kuroki, MD, MSCI – Gynecologic Oncology, Washington University School of Medicine in St. Louis
  • Ken Lin, MD, PhD – Gynecologic Oncology, Montefiore Medical Center
  • Gina Mantia-Smaldone, MD – Gynecologic Oncology, Fox Chase Cancer Center
  • Kathryn Mills, MD – Gynecologic Oncology, University of Chicago
  • Mary Mullen, MD – Gynecologic Oncology, Washington University School of Medicine in St. Louis
  • Kathryn Pennington, MD – Gynecologic Oncology – University of Washington
  • Rebecca Previs, MD, BS, MS – Gynecologic Oncology, Duke Health
  • Tyler Robin, MD, PhD – Radiation Oncology, University of Colorado
  • Jennifer Veneris, MD, PhD – Medical Oncology, Dana-Farber Cancer Institute
  • Danielle Vicus, MD, MSc, FRCSC – Gynecologic Oncology, Sunnybrook Health Sciences Center
  • Heather Williams, MD – Gynecologic Oncology, Medical College of Georgia
  • Lyndsay Willmott, MD – Gynecologic Oncology, Arizona Oncology
  • Boris Winterhoff, MD, MS – Gynecologic Oncology – University Minnesota
  • Juliet Wolford, MLARP, MS-BATS, MD – Gynecologic Oncology, University of California, Irvine
  • Emi Yoshida, MD – Radiation Oncology, University of California, San Francisco

Education and Mentoring Committee

This program is indebted to the Society of Gynecologic Oncology and NRG Oncology for their partnership in this effort and thanks the following members of the Education and Mentoring Committee and others that assisted in the review of submitted proposals.

Ronald D. Alvarez, MD – Chair
Angeles Alvarez Secord, MD, MHSc – Co-chair
Elise C. Kohn, MD – Head, NCI DCTD Gynecologic Cancer Therapeutics
Laurel W. Rice, MD – Past President, SGO
Warner K. Huh, MD – President, SGO
David G. Mutch, MD –Chair, FWC
Michelle Small – GOG-Foundation Administrative Support

Additional review assistance provided by Carol A. Aghajanian, MD and Robert L. Coleman, MD